Skip to content
ETopical – Lifestyle
Author:
4D Molecular Therapeutics, Inc.
4DMT Announces Presentation at 44th Annual Scientific Meeting of the American Society of Retina Specialists
June 30, 2026
4DMT Completes Enrollment for 4FRONT-2 Global Phase 3 Clinical Trial of 4D-150 in Wet AMD
June 29, 2026
4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital
June 29, 2026
4DMT Announces New Employment Inducement Grants
June 12, 2026
4DMT to Participate in Upcoming Investor Conferences
May 27, 2026
←
Previous Page
1
2